Join Growin Stock Community!

Azitra, inc.AZTR.US Overview

US StockHealthcare
(No presentation for AZTR)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

AZTR AI Insights

AZTR Overall Performance

AZTR AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

AZTR Recent Performance

-5.43%

Azitra, inc.

0.05%

Avg of Sector

-0.31%

S&P500

AZTR PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

AZTR Key Information

AZTR Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

AZTR Profile

Azitra, Inc., a pre-clinical biopharmaceutical company, focuses on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It is developing ATR-12, a genetically modified strain of S. epidermidis for treating Netherton syndrome, a skin disease; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash experienced by cancer patients undergoing epidermal growth factor receptor inhibitor; and ATR-01, an engineered recombinant human filaggrin protein for treating ichthyosis vulgaris, a skin disease. The company was incorporated in 2014 and is based in Branford, Connecticut.

Price of AZTR

AZTR FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

AZTR Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.07
PE Ratio (TTM)
0.01
Forward PE
-
PS Ratio (TTM)
438.62
PB Ratio
0.82
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
100.00%
Net Margin
-121372.83%
Revenue Growth (YoY)
-100.00%
Profit Growth (YoY)
-100.00%
3-Year Revenue Growth
-100.00%
3-Year Profit Growth
-100.00%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.07
PE Ratio (TTM)
0.01
Forward PE
-
PS Ratio (TTM)
438.62
PB Ratio
0.82
Price-to-FCF
-
Gross Margin
100.00%
Net Margin
-121372.83%
Revenue Growth (YoY)
-100.00%
Profit Growth (YoY)
-100.00%
3-Year Revenue Growth
-100.00%
3-Year Profit Growth
-100.00%

  • When is AZTR's latest earnings report released?

    The most recent financial report for Azitra, inc. (AZTR) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating AZTR's short-term business performance and financial health. For the latest updates on AZTR's earnings releases, visit this page regularly.

  • How much debt does AZTR have?

    As of the end of the reporting period, Azitra, inc. (AZTR) had total debt of 422.08K, with a debt ratio of 0.08. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does AZTR have?

    At the end of the period, Azitra, inc. (AZTR) held Total Cash and Cash Equivalents of 2.07M, accounting for 0.41 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Is AZTR's EPS continuing to grow?

    According to the past four quarterly reports, Azitra, inc. (AZTR)'s earnings per share (EPS) shows a declining trend, with the latest EPS at 0.81. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of AZTR?

    Azitra, inc. (AZTR)'s Free Cash Flow (FCF) for the period is -2.9M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 12.21% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of AZTR?

    The latest valuation data shows Azitra, inc. (AZTR) has a Price-To-Earnings (PE) ratio of -0.26 and a Price/Earnings-To-Growth (PEG) ratio of 0. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.